BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37648804)

  • 1. Influence of mammographic density and compressed breast thickness on true mammographic sensitivity: a cohort study.
    Strandberg R; Illipse M; Czene K; Hall P; Humphreys K
    Sci Rep; 2023 Aug; 13(1):14194. PubMed ID: 37648804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
    Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
    Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening Programme.
    Moshina N; Roman M; Waade GG; Sebuødegård S; Ursin G; Hofvind S
    Eur Radiol; 2018 Apr; 28(4):1662-1672. PubMed ID: 29098437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A statistical model of breast cancer tumour growth with estimation of screening sensitivity as a function of mammographic density.
    Abrahamsson L; Humphreys K
    Stat Methods Med Res; 2016 Aug; 25(4):1620-37. PubMed ID: 23839121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
    Bailey SL; Sigal BM; Plevritis SK
    J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of compressed breast thickness and dose on lesion detectability in digital mammography: FROC study with simulated lesions in real mammograms.
    Salvagnini E; Bosmans H; Van Ongeval C; Van Steen A; Michielsen K; Cockmartin L; Struelens L; Marshall NW
    Med Phys; 2016 Sep; 43(9):5104. PubMed ID: 27587041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
    Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case-control study.
    Velásquez García HA; Sobolev BG; Gotay CC; Wilson CM; Lohrisch CA; Lai AS; Aronson KJ; Spinelli JJ
    Breast Cancer Res Treat; 2018 Jul; 170(1):159-168. PubMed ID: 29516373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of screening performance metrics and patient dose of two mammographic image acquisition modes in the Danish National Breast Cancer Screening Programme.
    Abdi AJ; Fieselmann A; Pfaff H; Mertelmeier T; Larsen LB
    Eur J Radiol; 2018 Aug; 105():188-194. PubMed ID: 30017278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic density and breast cancer screening.
    Bell RJ
    Climacteric; 2020 Oct; 23(5):460-465. PubMed ID: 32643449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort.
    Maskarinec G; Dartois L; Delaloge S; Hopper J; Clavel-Chapelon F; Baglietto L
    Cancer Epidemiol; 2017 Aug; 49():156-160. PubMed ID: 28697417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
    Hinton B; Ma L; Mahmoudzadeh AP; Malkov S; Fan B; Greenwood H; Joe B; Lee V; Strand F; Kerlikowske K; Shepherd J
    Med Phys; 2019 Mar; 46(3):1309-1316. PubMed ID: 30697755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer.
    Strand F; Humphreys K; Eriksson M; Li J; Andersson TM; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Int J Cancer; 2017 Jan; 140(1):34-40. PubMed ID: 27615710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
    BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.